Niquitin Clear (Nicotine)

Nicotine, the active ingredient in Niquitin Clear, is a nicotine drug class presented as a transdermal patch for transdermal use. It treats nicotine dependence and aids smoking cessation in adults.

GNH USA supplies Niquitin Clear as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Nicotine transdermal patch is used in the management of nicotine dependence, a component of tobacco use disorder.

- Smoking cessation: helps reduce withdrawal symptoms and cravings during quit attempts. - Tobacco dependence: provides a controlled nicotine supply to support gradual reduction. - Nicotine withdrawal: alleviates acute symptoms such as irritability and anxiety.

Common Side Effects: - Skin irritation at the application site: redness, itching, or mild burning. - Sleep disturbance: vivid dreams or difficulty falling asleep. - Nausea: mild gastrointestinal upset. - Headache: transient tension-type headache.

Serious or Rare Side Effects: - Allergic reaction: rash, swelling, or hives requiring medical attention. - Severe skin necrosis: localized tissue damage at the patch site. - Cardiovascular events: tachycardia, hypotension, or arrhythmia in susceptible individuals.

Before using Niquitin Clear, consider the following precautions: - Assess nicotine dependence level: determine appropriate patch strength. - Recent cardiovascular events: avoid in patients with recent myocardial infarction or unstable angina. - Concomitant nicotine products: do not use other nicotine replacement therapies simultaneously. - Heat exposure: keep patch away from external heat sources to prevent increased nicotine release. - Store at room temperature: keep in the original packaging, protect from moisture and direct sunlight.

Nicotine patches can interact with several medicines. Review the following groups:

Major Interactions (Avoid): - Other nicotine replacement products: risk of nicotine overdose. - Monoamine oxidase inhibitors (MAOIs): may potentiate hypertensive reactions.

Moderate Interactions (Monitor Closely): - CYP1A2 substrates (e.g., theophylline, clozapine): nicotine induces metabolism, possibly reducing drug levels. - Certain antidepressants (e.g., SSRIs, SNRIs): may alter nicotine metabolism and affect efficacy. - Alcohol: can increase nicotine cravings and affect tolerability.